hTERT regulation by NF-κB and c-myc in irradiated HER2-positive breast cancer cells

References

• Asanuma H, Torigoe T, Kamiguchi K, Hirohashi Y, Ohmura T, Hirata K, Sato M, Sato N. 2005. Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells. Cancer Research 65:11018–11025.
   PubMed Web of Science ®Google Scholar
• Baud V, Karin M. 2009. Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls. Nature Reviews Drug Discovery 8:33–40.
   PubMed Web of Science ®Google Scholar
• Cosgrave N, Hill AD, Young LS. 2006. Growth factor-dependent regulation of survivin by c-myc in human breast cancer. Journal of Molecular Endocrinology 37:377–390.
   PubMedGoogle Scholar
• Flint J, Craddock CF, Villegas A, Bentley DP, Williams HJ, Galanello R, Cao A, Wood WG, Ayyub H, Higgs DR. 1994. Healing of broken human chromosomes by the addition of telomeric repeats. American Journal of Human Genetics 55:505–512.
   PubMed Web of Science ®Google Scholar
• Fujiki T, Miura T, Maura M, Shiraishi H, Nishimura S, Imada Y, Uehara N, Tashiro K, Shirahata S, Katakura Y. 2007. TAK1 represses transcription of the human telomerase reverse transcriptase gene. Oncogene 26:5258–5266.
   PubMedGoogle Scholar
• Gee JM, Nicholson RI. 2003. Expanding the therapeutic repertoire of epidermal growth factor receptor blockade: Radiosensitization. Breast Cancer Research 5:126–129.
   PubMed Web of Science ®Google Scholar
• Goueli BS, Janknecht R. 2004. Upregulation of the catalytic telomerase subunit by the transcription factor ER81 and oncogenic HER2/Neu, Ras, or Raf. Molecular and Cellular Biology 24:25–35.
   PubMedGoogle Scholar
• Horikawa I, Barrett JC. 2003. Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms. Carcinogenesis 24:1167–1176.
   PubMed Web of Science ®Google Scholar
• Hynes NE, Stern DF. 1994. The biology of erbB-2/neu/HER-2 and its role in cancer. Biochimica et Biophysica Acta 1198:165–184.
   PubMed Web of Science ®Google Scholar
• Jameel JK, Rao VS, Cawkwell L, Drew PJ. 2004. Radioresistance in carcinoma of the breast. Breast 13:452–460.
   PubMed Web of Science ®Google Scholar
• Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. 2009. Cancer statistics, 2009. CA: A Cancer Journal for Clinicians 59:225–249.
   PubMed Web of Science ®Google Scholar
• Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW. 1994. Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011–2015.
   PubMed Web of Science ®Google Scholar
• Kyo S, Inoue M. 2002. Complex regulatory mechanisms of telomerase activity in normal and cancer cells: How can we apply them for cancer therapy? Oncogene 21:688–697.
   PubMed Web of Science ®Google Scholar
• Kyo S, Takakura M, Kanaya T, Zhuo W, Fujimoto K, Nishio Y, Orimo A, Inoue M. 1999. Estrogen activates telomerase. Cancer Research 59:5917–5921.
   PubMed Web of Science ®Google Scholar
• Liang K, Lu Y, Jin W, Ang KK, Milas L, Fan Z. 2003. Sensitization of breast cancer cells to radiation by trastuzumab. Molecular Cancer Therapeutics 2:1113–1120.
   PubMed Web of Science ®Google Scholar
• Lin Z, Lim S, Viani MA, Sapp M, Lim MS. 2001. Down-regulation of telomerase activity in malignant lymphomas by radiation and chemotherapeutic agents. American Journal of Pathology 159:711–719.
   PubMedGoogle Scholar
• Pandita TK, Roti Roti JL. 2003. Role of telomerase in radiocurability (Review). Oncology Reports 10:263–270.
   PubMedGoogle Scholar
• Papanikolaou V, Iliopoulos D, Dimou I, Dubos S, Tsougos I, Theodorou K, Kitsiou-Tzeli S, Tsezou A. 2009. The involvement of HER2 and p53 status in the regulation of telomerase in irradiated breast cancer cells. International Journal of Oncology 35:1141–1149.
   PubMedGoogle Scholar
• Satra M, Tsougos I, Papanikolaou V, Theodorou K, Kappas C, Tsezou A. 2006. Correlation between radiation-induced telomerase activity and human telomerase reverse transcriptase mRNA expression in HeLa cells. International Journal of Radiation Biology 82:401–409.
   PubMed Web of Science ®Google Scholar
• Sawant SG, Gregoire V, Dhar S, Umbricht CB, Cvilic S, Sukumar S, Pandita TK. 1999. Telomerase activity as a measure for monitoring radiocurability of tumor cells. Faseb Journal 13:1047–1054.
   PubMed Web of Science ®Google Scholar
• Sethi G, Ahn KS, Aggarwal BB. 2008. Targeting nuclear factor-kappa B activation pathway by thymoquinone: Role in suppression of antiapoptotic gene products and enhancement of apoptosis. Molecular Cancer Research 6:1059–1070.
   PubMed Web of Science ®Google Scholar
• Shay JW, Bacchetti S. 1997. A survey of telomerase activity in human cancer. European Journal of Cancer 33:787–791.
   PubMed Web of Science ®Google Scholar
• Tsezou A, Oikonomou P, Kollia P, Mademtzis I, Kostopoulou E, Messinis I, Vamvakopoulos N. 2005. The role of human telomerase catalytic subunit mRNA expression in cervical dysplasias. Experimental Biology and Medicine (Maywood) 230:263–270.
   PubMedGoogle Scholar
• Wang Z, Kyo S, Takakura M, Tanaka M, Yatabe N, Maida Y, Fujiwara M, Hayakawa J, Ohmichi M, Koike K, et al. 2000. Progesterone regulates human telomerase reverse transcriptase gene expression via activation of mitogen-activated protein kinase signaling pathway. Cancer Research 60:5376–5381.
   PubMed Web of Science ®Google Scholar
• Wilkie AO, Lamb J, Harris PC, Finney RD, Higgs DR. 1990. A truncated human chromosome 16 associated with alpha thalassaemia is stabilized by addition of telomeric repeat (TTAGGG)n. Nature 346: 868–871.
   PubMedGoogle Scholar
• Xu D, Popov N, Hou M, Wang Q, Bjorkholm M, Gruber A, Menkel AR, Henriksson M. 2001. Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells. Proceedings of the National Academy of Sciences of the USA 98:3826–3831.
   PubMed Web of Science ®Google Scholar
• Yarden Y. 2001. Biology of HER2 and its importance in breast cancer. Oncology 61(Suppl. 2):1–13.
   PubMed Web of Science ®Google Scholar